These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9566453)

  • 1. Carrier screening for cystic fibrosis: costs and clinical outcomes.
    Asch DA; Hershey JC; Dekay ML; Pauly MV; Patton JP; Jedrziewski MK; Frei F; Giardine R; Kant JA; Mennuti MT
    Med Decis Making; 1998; 18(2):202-12. PubMed ID: 9566453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preconception screening of parents and carrier state of cystic fibrosis in the Netherlands: expenses and savings].
    Verheij JB; Hilderink HB; Verzijl JG; Wildhagen MF; Habbema JD; ten Kate LP
    Ned Tijdschr Geneeskd; 1998 Mar; 142(13):706-10. PubMed ID: 9623144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis.
    Maxwell S; Brameld K; Youngs L; Geelhoed E; O'Leary P
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):51-9. PubMed ID: 20218998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of carrier screening for cystic fibrosis in Australia.
    Norman R; van Gool K; Hall J; Delatycki M; Massie J
    J Cyst Fibros; 2012 Jul; 11(4):281-7. PubMed ID: 22425241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
    Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of antenatal screening for cystic fibrosis.
    Cuckle HS; Richardson GA; Sheldon TA; Quirke P
    BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between carrier screening and incidence of cystic fibrosis.
    Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM
    JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preconception cystic fibrosis carrier screening: costs and consequences.
    Weijers-Poppelaars FA; Wildhagen MF; Henneman L; Cornel MC; Kate LP
    Genet Test; 2005; 9(2):158-66. PubMed ID: 15943557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for cystic fibrosis carriers: an economic evaluation.
    Rowley PT; Loader S; Kaplan RM
    Am J Hum Genet; 1998 Oct; 63(4):1160-74. PubMed ID: 9758600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cystic fibrosis carrier screening cost effective?
    Wei S; Quigg MH; Monaghan KG
    Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal and preconception population carrier screening for cystic fibrosis in Australia: where are we up to?
    Massie J; Ioannou L; Delatycki M
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):503-9. PubMed ID: 25350764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis.
    Davis LB; Champion SJ; Fair SO; Baker VL; Garber AM
    Fertil Steril; 2010 Apr; 93(6):1793-804. PubMed ID: 19439290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs, effects, and savings of screening for cystic fibrosis gene carriers.
    Wildhagen MF; Hilderink HB; Verzijl JG; Verheij JB; Kooij L; Tijmstra T; ten Kate LP; Habbema JD
    J Epidemiol Community Health; 1998 Jul; 52(7):459-67. PubMed ID: 9799881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effectiveness analysis of prenatal carrier screening for cystic fibrosis.
    Vintzileos AM; Ananth CV; Smulian JC; Fisher AJ; Day-Salvatore D; Beazoglou T
    Obstet Gynecol; 1998 Apr; 91(4):529-34. PubMed ID: 9540935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The introduction of cystic fibrosis carrier screening into clinical practice: policy considerations.
    Wilfond BS; Fost N
    Milbank Q; 1992; 70(4):629-59. PubMed ID: 1435628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families.
    Henneman L; Kooij L; Bouman K; ten Kate LP
    Am J Med Genet; 2002 Jul; 110(4):324-31. PubMed ID: 12116205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.
    Ioannou L; Delatycki MB; Massie J; Hodgson J; Lewis S
    J Genet Couns; 2015 Dec; 24(6):987-1000. PubMed ID: 25925605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.